daleuton
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
6
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2015 (NCT02211417)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Leukocyte surface antigen CD47ACTIVATOR
CD47 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ds107
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03817190 | Phase 2 | Jun 30, 2019 | DS Biopharma |
| NCT02864498 | Phase 2 | Jan 1, 2017 | DS Biopharma |
| NCT02925793 | Phase 2 | Dec 1, 2016 | DS Biopharma |
| NCT03676933 | Phase 2 | Oct 31, 2015 | DS Biopharma |
| NCT03676036 | Phase 2 | Jun 30, 2015 | DS Biopharma |
| NCT02211417 | Phase 2 | Jan 1, 2015 | DS Biopharma |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| DS Biopharma | For profit | 6 | 6 | 1 | 2015 |
1 organizations
Page 1 / 1